SARS-CoV-2 can cause buildup of Alzheimer’s-related peptides in retina

A new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into a hypothesis about the origin of Alzheimer’s disease.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup